Search
    Skip to main content
    Advertisement

    Johnson and Johnson

    1. Industry Sectors
    2. Pharmaceuticals
    3. Johnson and Johnson
    “Our goal is a solution for every bladder cancer patient” Johnson & Johnson (Press Release)14:17
    Does the Kenvue spinoff signal a new opportunity for Johnson & Johnson in 2025? Simply Wall St22:09
    FDA clears Johnson & Johnson's Darzalex Faspro, enabling early intervention in myeloma progression Benzinga18:02
    J&J’s Darzalex gains first FDA approval in smouldering multiple myeloma Pharmaceutical Technology16:09
    FDA approved Darzalex Faspro® for adult patients with high-risk smoldering multiple myeloma PR Newswire (Press Release)13:38
    Carefirst urges ban on j&j character talk at Stelara trial Law36002:42
    Darzalex Faspro® is the first and only treatment approved by the U.S. FDA for patients with… PR Newswire (Press Release)22:10

    Latest News

    Yesterday
    “Our goal is a solution for every bladder cancer patient” Johnson & Johnson (Press Release)14:17 10-Nov-25
    Yuhan, Janssen Korea to jointly promote Leclaza+Rybrevant combo for EGFR-mutated lung cancer Korea Biomedical Review06:10 10-Nov-25
    In the last 7 days
    FDA Clears Johnson & Johnson's Darzalex Faspro, Enabling Early Intervention In Myeloma Progression Benzinga18:02 7-Nov-25
    J&J’s Darzalex gains first FDA approval in smouldering multiple myeloma Pharmaceutical Technology16:09 7-Nov-25
    FDA Approved DARZALEX Faspro® for Adult Patients with High-Risk Smoldering Multiple Myeloma PR Newswire (Press Release)13:38 7-Nov-25
    CareFirst Urges Ban On J&J Character Talk At Stelara Trial Law36002:42 7-Nov-25
    DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with… PR Newswire (Press Release)22:10 6-Nov-25
    STAT Plus: Mark Cuban is trying to shake up biosimilar pricing with a version of J&J’s… STAT18:28 6-Nov-25
    J&J’s Caplyta wins MDD approval to extend revenue horizon Pharmaceutical Technology17:56 6-Nov-25
    J&J adds first new indication for Caplyta since takeover pharmaphorum14:10 6-Nov-25
    STAT Plus: FDA approves J&J’s antipsychotic drug to treat depression STAT12:32 6-Nov-25
    J&J, Kenvue Rebuffed on Fresh Look at IPO Case, Early Appeal Bloomberg Law23:41 5-Nov-25
    Johnson & Johnson to Participate in the Citi’s 2025 Global Healthcare Conference Johnson & Johnson (Press Release)21:52 5-Nov-25
    Texas Sues Johnson & Johnson and Kenvue Over Tylenol- Scientific Evidence, Regulatory Shifts, and the Future of OTC… National Law Review15:52 5-Nov-25
    J&J, Kenvue Must Still Face IPO Fraud Claims, Judge Rules Law36003:27 5-Nov-25
    Does the Kenvue Spinoff Signal a New Opportunity for Johnson & Johnson in 2025? Simply Wall St22:09 4-Nov-25
    Johnson & Johnson reinforces its leadership in hematology at ASH 2025 unveiling new paradigm-shifting research Johnson & Johnson (Press Release)21:25 4-Nov-25
    Johnson & Johnson One Year Data Demonstrate Durable Performance and Safety of the Shockwave Javelin Peripheral IVL… Johnson & Johnson (Press Release)19:54 4-Nov-25
    Sun Care Products Market Research Report 2025-2030 with Exclusive Data on 30+ Vendors Including … Business Wire (Press Release)12:54 4-Nov-25
    Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn Pharmaceutical Technology11:27 4-Nov-25
    J&J MedTech reports one-year study results of peripheral IVL system Verdict Medical Devices09:58 4-Nov-25
    J&J chief voices optimism about mitigating Trump tariff impact Nikkei Asian Review07:31 4-Nov-25
    In the last month
    Kenvue Acquired by Kimberly-Clark in $48.7 Billion Deal to Form Consumer Staples Giant IBTimes.co.uk21:28 3-Nov-25
    Johnson & Johnson Confirms Durability of IVL in Complex, Below-the-Knee Anatomy in Late-Breaking Presentation at VIVA… Johnson & Johnson (Press Release)19:18 3-Nov-25
    Tylenol maker Kenvue agrees $48.7bn Kimberly-Clark takeover pharmaphorum13:49 3-Nov-25
    Kimberly-Clark to Acquire Kenvue Women's Wear Daily12:21 3-Nov-25
    Bristol Myers Squibb Showcases New Long-Term and Real-World Data From Cardiovascular Portfolio… Business Wire (Press Release)12:07 3-Nov-25
    Will President Trump's Tylenol Claims Hurt These 2 Leading Pharmaceutical Stocks? The Motley Fool11:50 3-Nov-25
    Johnson & Johnson Stock: Is Wall Street Bullish or Bearish? Barchart09:39 3-Nov-25
    Johnson & Johnson Showcases Latest Advancements in Pulsed Field Ablation with Multiple Clinical and Real-world Studies… Johnson & Johnson (Press Release)02:10 3-Nov-25
    Jury Awards $20 MILLION in Casaretto v. Johnson & Johnson PRWeb (Press Release)02:08 2-Nov-25
    Ken Paxton to Newsmax: Acetaminophen Risky for Pregnant Women NewsMax00:51 1-Nov-25
    Johnson & Johnson submits application to U.S. FDA for STELARA® (ustekinumab) in the treatment of pediatric ulcerative… Johnson & Johnson (Press Release)20:05 31-Oct-25
    "Significant shift" as NICE widens prostate cancer drug use pharmaphorum13:13 31-Oct-25
    The Zacks Analyst Blog Highlights Broadcom, Johnson & Johnson, Palantir Technologies, Fossil Group and Moving iMage Zacks08:51 31-Oct-25
    J&J's Janssen Says 3rd Circ. Should Reverse $1.6B FCA Win Law36023:14 30-Oct-25
    Top Analyst Reports for Broadcom, Johnson & Johnson and Palantir Zacks22:09 30-Oct-25
    Protagonist Therapeutics (PTGX): Assessing Valuation After Breakthrough Phase 2b Results and Johnson & Johnson’s Phase… Simply Wall St16:38 30-Oct-25
    Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock Zacks14:41 30-Oct-25
    When chemistry corrects biology: the deuterated return of a MET inhibitor Drug Target Review09:09 30-Oct-25
    J&J Talc Unit Presses Doctors to Reveal Legal Defense Funders Bloomberg Law17:33 29-Oct-25
    Mothers of Children With Autism Say Paxton Is ‘Disgrace’ After Tylenol Lawsuit Dallas Observer16:32 29-Oct-25
    Big Pharma Betrayal: Paxton Targets Johnson & Johnson For Deceptive Tylenol Marketing The Dallas Express16:02 29-Oct-25
    Florida Jury Awards $20 Million in J&J Talcum Powder Mesothelioma Lawsuit Insurance Journal15:48 29-Oct-25
    Juvenile myasthenia gravis: Inside one adolescent’s journey Johnson & Johnson (Press Release)13:12 29-Oct-25
    Johnson & Johnson announces first head-to-head study comparing IMAAVY™ with an alternative FcRn … PR Newswire (Press Release)12:07 29-Oct-25
    Acetaminophen-autism link research gets boost from Texas Tylenol liability fraud lawsuit Just The News02:58 29-Oct-25
    Texas sues Johnson & Johnson over Tylenol-autism link claims CBS Austin00:14 29-Oct-25
    J&J Hit With $20M Verdict In Fla. Talc Trial Law36023:18 28-Oct-25
    Texas joins Trump’s ridiculous war on Tylenol Daily Kos23:04 28-Oct-25
    Texas sues Tylenol makers, claims they hid autism risk in unborn children The Telegraph, Calcutta23:02 28-Oct-25
    Texas AG Paxton to Newsmax: Tylenol Makers Hid Autism Risk NewsMax22:52 28-Oct-25
    Texas's anti-LGBTQ+ attorney general sues Tylenol company over autism claims Advocate.com22:28 28-Oct-25
    Texas Is Suing Tylenol Amid Trump’s Unproven Autism Claims Just Jared (Weblog)19:51 28-Oct-25
    Johnson & Johnson to Advance Robotics Development with NVIDIA Isaac for Healthcare Johnson & Johnson (Press Release)18:30 28-Oct-25
    Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety Benzinga17:27 28-Oct-25
    Texas sues Tylenol makers J&J and Kenvue, citing unproven link between the drug and autism CBC.ca17:26 28-Oct-25
    3M, J&J Mass Tort Funder Sues NY Law Firm for Investment Debacle Bloomberg Law17:06 28-Oct-25
    Texas Sues Tylenol Makers Over Claims of Links to Autism TIME17:03 28-Oct-25
    Texas Attorney General Ken Paxton announces Tylenol lawsuit KXII16:40 28-Oct-25
    Texas Sues Tylenol Makers J&J and Kenvue, Alleging They Hid Drug’s Autism Risks Insurance Journal16:23 28-Oct-25
    Texas sues Tylenol makers over alleged links to autism, ADHD Jurist16:15 28-Oct-25
    Texas sues Tylenol makers over Rfk Jr. autism claims The Independent16:01 28-Oct-25
    Headaches continue for Tylenol brand as Texas AG files lawsuit over alleged autism link The Blaze16:01 28-Oct-25
    Texas AG Ken Paxton files Tylenol lawsuit over autism claims CBS News15:44 28-Oct-25
    Texas AG sues Tylenol makers in test case of Trump administration’s autism claims The Washington Times15:40 28-Oct-25
    Texas sues Tylenol makers J&J and Kenvue, claiming they hid drug's autism risks Pittsburgh Tribune-Review15:35 28-Oct-25
    Texas sues Kenvue and J&J, Truth Social to offer prediction markets Yahoo! UK & Ireland14:54 28-Oct-25
    Texas sues J&J, Kenvue over Tylenol autism claim pharmaphorum14:49 28-Oct-25
    Texas AG sues Kenvue, J&J over 'deceptively marketing' Tylenol to pregnant women Fox News14:39 28-Oct-25
    Dow Movers: JNJ, SHW Nasdaq14:20 28-Oct-25
    Texas sues Tylenol makers over asserted autism link Courthouse News14:05 28-Oct-25
    Texas becomes first state to sue Tylenol maker over ties to autism pushed by Trump… Washington Examiner14:01 28-Oct-25
    Paxton sues pharmaceutical companies for 'deceptively marketing Tylenol to pregnant mothers' Just The News13:58 28-Oct-25
    Texas Sues J&J, Kenvue Over Alleged Autism Risks from Tylenol Bloomberg Law13:43 28-Oct-25
    J&J Talc Cancer Suits Rise 17% After Failed Settlement Push Insurance Journal13:36 28-Oct-25
    Texas sues Tylenol makers, claiming they hid autism risks Boston Globe13:35 28-Oct-25
    Texas Sues Tylenol Makers After Trump Links Drug To Autism Forbes13:24 28-Oct-25
    5 ways Johnson & Johnson is innovating in medicines and therapies Johnson & Johnson (Press Release)12:58 28-Oct-25
    Texas Sues Tylenol Maker, Citing Autism Risks and 'Deception' NewsMax12:40 28-Oct-25
    Texas sues Tylenol maker over claims it failed to warn pregnant women of autism risk MailOnline12:40 28-Oct-25
    Attorney General Paxton Sues Big Pharma Manufacturers for Deceptively Marketing Tylenol to Pregnant Mothers Despite… Texas Attorney General (Press Release)12:35 28-Oct-25
    Texas attorney general sues Tylenol company over autism claims The Texas Tribune12:17 28-Oct-25
    J&J’s Lisa LeCointe-Cephas Navigates Health Care on Her Terms Bloomberg Law09:04 28-Oct-25
    J&J Talc Cancer Suits Jump 17% After Failed Settlement Effort Insurance Claims Journal05:10 28-Oct-25
    J&J chair to share health care tech vision at APEC summit The Korea Herald01:47 28-Oct-25
    Chancery Lets J&J, Dow Fight To Save Asbestos Data Law36023:11 27-Oct-25
    J&J Talc Cancer Suits Rise 17% After Failed Settlement Effort Bloomberg Law17:33 27-Oct-25
    Hot Picks: Pharma stocks climb on innovation and new growth drivers BNN Bloomberg15:57 27-Oct-25
    3 Healthcare Stocks to Buy Hand Over Fist in October The Motley Fool15:08 27-Oct-25
    Here's Why Johnson & Johnson (JNJ) is a Strong Momentum Stock Zacks14:51 27-Oct-25
    Johnson and Johnson to spin off orthopaedics market Verdict Medical Devices12:51 27-Oct-25
    Johnson & Johnson Advances Polyphonic™ AI Fund for Surgery for Data-Driven Healthcare Johnson & Johnson (Press Release)12:09 27-Oct-25
    New study reveals substantial unmet need in psoriasis, shows strong patient and provider… PR Newswire (Press Release)12:03 27-Oct-25
    TREMFYA® (guselkumab), the first and only IL-23 inhibitor with a fully subcutaneous treatment… PR Newswire (Press Release)11:34 27-Oct-25
    Icotrokinra maintains standout combination of therapeutic benefit and a favorable safety… PR Newswire (Press Release)11:33 27-Oct-25
    Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever. The Motley Fool08:36 26-Oct-25
    Johnson & Johnson appeals €944,000 award to former Limerick hurler The Irish Times16:28 25-Oct-25
    Johnson & Johnson (JNJ): Assessing Valuation After Recent Share Price Momentum Simply Wall St14:37 25-Oct-25
    Published in The Lancet: Nipocalimab significantly decreased Sjögren’s disease (SjD) activity and severity through… Johnson & Johnson (Press Release)23:34 24-Oct-25
    Los Angeles Jury Awards $966M For Asbestos Talc-Related Mesothelioma JD Supra20:50 24-Oct-25
    Johnson & Johnson appeal €944,000 awarded to former hurler for workplace injury Irish Examiner19:13 24-Oct-25
    Johnson and Johnson appeals award of €944k to former Limerick hurler injured while rescuing co-worker BreakingNews.ie18:49 24-Oct-25
    Icotrokinra long-term results affirm promise of targeted oral peptide with high rates of durable skin clearance and… Johnson & Johnson (Press Release)13:03 24-Oct-25
    Johnson & Johnson MedTech Highlights Newest Impella Heart Pump and Long-Term Survival Data at TCT 2025 Johnson & Johnson (Press Release)13:03 24-Oct-25
    Delhi High Court stays regulator’s curb on Ors branding in relief for J&J arm Indian Express23:40 23-Oct-25
    J&J now faces talc cancer claims in the UK Chemistry World Magazine12:10 23-Oct-25
    Brown Rudnick Fights J&J Unit Over $4 Million Bankruptcy Tab Bloomberg Law10:01 23-Oct-25
    Johnson & Johnson under fire for asbestos use. Be aware of the risks Universul.net02:19 23-Oct-25
    Johnson & Johnson to Participate in the 7th Annual Wolfe Research Healthcare Conference Business Wire (Press Release)21:38 22-Oct-25
    Inside Dow Jones: Key Earnings Ahead for Some of the Index YTD Winners Investing.com UK16:04 22-Oct-25
    Jets to Collaborate with Johnson & Johnson to Promote Better Health in the Community New York Jets - Official Site15:37 22-Oct-25
    New York Jets to Collaborate with Johnson & Johnson to Promote Better Health in the Community PR Newswire (Press Release)15:31 22-Oct-25
    Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know Zacks15:10 22-Oct-25
    Talc lawsuit raises coverage questions for insurers Post Online12:10 22-Oct-25
    view more headlines
    10 Nov 14:17

    About our Johnson & Johnson news

    Latest news on Johnson & Johnson, the American multinational pharmaceutical, known for developing healthcare, pharmaceuticals, and consumer products. Stay updated on stories about their pioneering medical advancements, including vaccines, treatments, and medical devices. Explore insights into the company’s financial performance, share prices, leadership changes, and global strategies.

    Pharmaceuticals Top Stories

    FDA moves to streamline approach to biosimilars JD Supra17:37
    Eli Lilly keeps up ophthalmic gene therapy push with $475m MeiraGTx deal Pharmaceutical Technology17:04
    Pfizer to acquire Metsera after winning bidding contest against Novo Nordisk Proactive Investors (US)16:48
    Pfizer Inc. (PFE) is attracting investor attention: Here is what you should know Zacks15:05
    Novo Nordisk sways jury to reject whistleblower’s fraud claims Bloomberg Law14:08

    UK Top Stories

    BBC ‘can’t be held to ransom,’ says Dimbleby after Trump Panorama row The Independent22:00BBC Panorama BBC Donald Trump
    Trump threatens to sue BBC as UK broadcaster admits error in editing his Jan 6 speech AsiaOne01:50BBC Panorama BBC Donald Trump
    Woman, 34, stabbed in the neck in Birmingham dies of her injuries ITV11:07Knife Crime Birmingham West Midlands
    Pals of Birmingham stabbing victim Katie Fox share heartbreak to lose 'beautiful soul' The Mirror03:14Knife Crime Birmingham West Midlands
    British journalist to be freed from US immigration detention BBC02:03UK/US Immigration ICE
    British journalist Sami Hamdi expected to be released from ICE detention and return to UK CP2401:45UK/US Immigration ICE
    Rachel Reeves gives strongest sign yet she Will break Labour's manifesto vows on tax at Budget… MailOnline15:03Rachel Reeves Labour Party UK Politics
    Reeves signals manifesto-busting Budget will hike taxes Nation.Cymru16:29Rachel Reeves Labour Party UK Politics
    Girl, 4, fighting for life after being struck by firework in Burnley Metro.co.uk23:25Bonfire Night
    Teenager arrested as girl, 4, struck by firework fights for her life The Independent18:37Bonfire Night

    World Top Stories

    US Senate passes bill to end record government shutdown after bipartisan deal France 2403:21US Government Shutdown US Politics US
    US Senate approves bill to end the shutdown, sending it to the House euronews04:02US Government Shutdown US Politics US
    Trump vows to do everything he can to help Syria after landmark talks with Sharaa The Korea Herald01:47US/Syria Syria US
    Trump pledges support to Syria after historic meeting with rebel-turned-President India Today00:36US/Syria Syria US
    BBC says it received letter from Trump threatening legal action over the editing of his speech The Telegraph, Calcutta01:06BBC Donald Trump US
    Trump threatens to sue BBC as UK broadcaster admits error in editing his Jan 6 speech AsiaOne01:50BBC Donald Trump US
    Syrian president rules out normalization deal with Israel for now Anadolu Agency00:11US/Syria Syria Donald Trump
    Syria's al Sharaa rules out normalisation talks with Israel for now TRT World01:30US/Syria Syria Donald Trump
    China, Japan trade sharp words over Taiwan Anadolu Agency20:25Japan/China Taiwan Japan
    Japan, China exchange barbs after Takaichi’s remarks on Taiwan The Washington Times22:30Japan/China Taiwan Japan
    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.